These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 36898675)
1. Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1. Metry EL; Garrelfs SF; Peters-Sengers H; Vaz FM; Bijlsma JA; Neradova A; Oosterveld MJS; Groothoff JW Nephrol Dial Transplant; 2023 Jun; 38(7):1773-1775. PubMed ID: 36898675 [No Abstract] [Full Text] [Related]
2. Glycolate determination detects type I primary hyperoxaluria in dialysis patients. Marangella M; Petrarulo M; Bianco O; Vitale C; Finocchiaro P; Linari F Kidney Int; 1991 Jan; 39(1):149-54. PubMed ID: 2002628 [TBL] [Abstract][Full Text] [Related]
3. Re: The Effects of the Inactivation of Hydroxyproline Dehydrogenase on Urinary Oxalate and Glycolate Excretion in Mouse Models of Primary Hyperoxaluria. Assimos DG J Urol; 2020 May; 203(5):876. PubMed ID: 32073946 [No Abstract] [Full Text] [Related]
4. STUDIES ON PRIMARY HYPEROXALURIA. II. URINARY OXALATE, GLYCOLATE, AND GLYOXYLATE MEASUREMENT BY ISOTOPE DILUTION METHODS. HOCKADAY TD; FREDERICK EW; CLAYTON JE; SMITH LH J Lab Clin Med; 1965 Apr; 65():677-87. PubMed ID: 14279147 [No Abstract] [Full Text] [Related]
5. Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial. Frishberg Y; DeschĂȘnes G; Groothoff JW; Hulton SA; Magen D; Harambat J; Van't Hoff WG; Lorch U; Milliner DS; Lieske JC; Haslett P; Garg PP; Vaishnaw AK; Talamudupula S; Lu J; Habtemariam BA; Erbe DV; McGregor TL; Cochat P; Clin J Am Soc Nephrol; 2021 Jul; 16(7):1025-1036. PubMed ID: 33985991 [TBL] [Abstract][Full Text] [Related]
6. Plasma and urine glycolate assays for differentiating the hyperoxaluria syndromes. Marangella M; Petrarulo M; Vitale C; Cosseddu D; Linari F J Urol; 1992 Sep; 148(3 Pt 2):986-9. PubMed ID: 1507356 [TBL] [Abstract][Full Text] [Related]
7. Endogenous Oxalate Production in Primary Hyperoxaluria Type 1 Patients. Garrelfs SF; van Harskamp D; Peters-Sengers H; van den Akker CHP; Wanders RJA; Wijburg FA; van Goudoever JB; Groothoff JW; Schierbeek H; Oosterveld MJS J Am Soc Nephrol; 2021 Dec; 32(12):3175-3186. PubMed ID: 34686543 [TBL] [Abstract][Full Text] [Related]
8. Long-term survival on renal replacement therapy for primary hyperoxaluria type I. Calzavara P; Marangella M; Petrarulo M; Ballanti P; Bonucci E; Calconi G; Maresca MC; da Porto A; Vianello A Nephron; 1993; 63(2):217-21. PubMed ID: 8450916 [TBL] [Abstract][Full Text] [Related]
9. Simple, fast and inexpensive quantification of glycolate in the urine of patients with primary hyperoxaluria type 1. Boehm T; Martin-Higueras C; Friesser E; Zitta C; Wallner S; Walli A; Kovacevic K; Hubmann H; Klavins K; Macheroux P; Hoppe B; Jilma B Urolithiasis; 2023 Mar; 51(1):49. PubMed ID: 36920530 [TBL] [Abstract][Full Text] [Related]
11. The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria. Buchalski B; Wood KD; Challa A; Fargue S; Holmes RP; Lowther WT; Knight J Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165633. PubMed ID: 31821850 [TBL] [Abstract][Full Text] [Related]
12. Urinary oxalate and glycolate excretion and plasma oxalate concentration. Barratt TM; Kasidas GP; Murdoch I; Rose GA Arch Dis Child; 1991 Apr; 66(4):501-3. PubMed ID: 2031609 [TBL] [Abstract][Full Text] [Related]
13. Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria. Morgan SH; Purkiss P; Watts RW; Mansell MA Nephron; 1987; 46(3):253-7. PubMed ID: 3306417 [TBL] [Abstract][Full Text] [Related]
14. Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria. Marangella M; Petrarulo M; Cosseddu D; Vitale C; Linari F Am J Kidney Dis; 1992 Jun; 19(6):546-53. PubMed ID: 1595703 [TBL] [Abstract][Full Text] [Related]
15. Oxalate removal in type I hyperoxaluria or acquired oxalosis using HD and equilibration PD. Bunchman TE; Swartz RD Perit Dial Int; 1994; 14(1):81-4. PubMed ID: 8312423 [No Abstract] [Full Text] [Related]
16. An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria. Liebow A; Li X; Racie T; Hettinger J; Bettencourt BR; Najafian N; Haslett P; Fitzgerald K; Holmes RP; Erbe D; Querbes W; Knight J J Am Soc Nephrol; 2017 Feb; 28(2):494-503. PubMed ID: 27432743 [TBL] [Abstract][Full Text] [Related]
17. Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study. Hoppe B; Pellikka PA; Dehmel B; Banos A; Lindner E; Herberg U Nephrol Dial Transplant; 2021 Jul; 36(8):1464-1473. PubMed ID: 32810261 [TBL] [Abstract][Full Text] [Related]
18. Oxalate removal by daily dialysis in a patient with primary hyperoxaluria type 1. Yamauchi T; Quillard M; Takahashi S; Nguyen-Khoa M Nephrol Dial Transplant; 2001 Dec; 16(12):2407-11. PubMed ID: 11733634 [TBL] [Abstract][Full Text] [Related]
19. Renal transplantation in primary hyperoxaluria. Watts RW; Morgan SH; Mansell MA; Purkiss P Ann Acad Med Singap; 1987 Apr; 16(2):337-9. PubMed ID: 3318661 [TBL] [Abstract][Full Text] [Related]
20. The determination of oxalate in haemodialysate and plasma: a means to detect and study 'hyperoxaluria' in haemodialysed patients. Wolthers BG; Meijer S; Tepper T; Hayer M; Elzinga H Clin Sci (Lond); 1986 Jul; 71(1):41-7. PubMed ID: 3709074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]